Autolus Therapeutics (Autolus Therapeutics) Ending Cash Position : $759.54 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Autolus Therapeutics Ending Cash Position?

Autolus Therapeutics's Ending Cash Position for the quarter that ended in Mar. 2024 was $759.54 Mil.

Autolus Therapeutics's quarterly Ending Cash Position declined from Sep. 2023 ($256.85 Mil) to Dec. 2023 ($240.34 Mil) but then increased from Dec. 2023 ($240.34 Mil) to Mar. 2024 ($759.54 Mil).

Autolus Therapeutics's annual Ending Cash Position increased from Dec. 2021 ($310.68 Mil) to Dec. 2022 ($382.76 Mil) but then declined from Dec. 2022 ($382.76 Mil) to Dec. 2023 ($240.34 Mil).

Autolus Therapeutics Ending Cash Position Historical Data

The historical data trend for Autolus Therapeutics's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Autolus Therapeutics Ending Cash Position Chart

Autolus Therapeutics Annual Data

Trend

Sep16

Sep17

Sep18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

211.43

154.09

310.68

382.76

240.34

Autolus Therapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															343.36	307.83	256.85	240.34	759.54

Autolus Therapeutics Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Autolus Therapeutics's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	382.761	+	-142.426
	=	240.34

Autolus Therapeutics's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	240.335	+	519.209
	=	759.54

Autolus Therapeutics Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Autolus Therapeutics's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Autolus Therapeutics (Autolus Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Autolus Therapeutics PLC (NAS:AUTL) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

6A3A:Germany

Address

191 Wood Lane, The MediaWorks, London, GBR, W12 7FP

Website

https://www.autolus.com

Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.